AudioCure Pharma
Berlin
About AudioCure Pharma
AudioCure Pharma is a pharmaceutical company with a focus on hearing impairments. Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to the discovery and preclinical development of drug candidates. He is joined by highly skilled scientists and executives as well as a tight-knit network of academic partners, internationally renowned advisors and strategic investors. AudioCure is based in Berlin, Germany. Their office is located in a peaceful courtyard in the central area of Mitte. As such, they benefit from being within easy reach of the main train station and many other Berlin high-tech companies and universities while also enjoying the hustle and bustle of this vibrant capital city. They have close ties to the Charité University which allows for a close interaction with the experts of this world renowned institution. Their front-runner compound: AC102, is currently in late stage preclinical development for the treatment of acute noise-induced hearing loss having successfully demonstrated preclinical proof of concept in 2016.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2016)
- Website: audiocure.com
- Phone: +49 (30) 221 8397 14
Industries & Categories
Biotechnology, Education, Emergency Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/audiocure-pharma-86629 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.